Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice
about
Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative diseaseNeurotrophic factors in Alzheimer’s disease: role of axonal transportAlzheimer's disease as homeostatic responses to age-related myelin breakdownRodent models of neuroinflammation for Alzheimer's diseaseChronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's diseaseElevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model.Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic miceA new brain drug delivery strategy: focused ultrasound-enhanced intranasal drug deliveryIntranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice.The CC chemokine receptor 5 regulates olfactory and social recognition in mice.Increased expression of the homologue of enhancer-of-split 1 protects neurons from beta amyloid neurotoxicity and hints at an alternative role for transforming growth factor beta1 as a neuroprotectorThe modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration.Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study.Small molecule activators of the Trk receptors for neuroprotectionImprovement of sciatic nerve regeneration using laminin-binding human NGF-beta.Sleeping together using social interactions to understand the role of sleep in plasticity.Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke.Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structuresDissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegenerationIntranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.Recombinant human nerve growth factor with a marked activity in vitro and in vivo.Intranasal "painless" human Nerve Growth Factor [corrected] slows amyloid neurodegeneration and prevents memory deficits in App X PS1 miceMethylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice.Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brain.Nerve growth factor and its receptor in schizophrenia.Consumption of molecular hydrogen prevents the stress-induced impairments in hippocampus-dependent learning tasks during chronic physical restraint in mice.Butyrylcholinesterase attenuates amyloid fibril formation in vitro.Regular moderate or intense exercise prevents depression-like behavior without change of hippocampal tryptophan content in chronically tryptophan-deficient and stressed miceIntranasal delivery of plasma and platelet growth factors using PRGF-Endoret system enhances neurogenesis in a mouse model of Alzheimer's disease.ERK pathway activation bidirectionally affects visual recognition memory and synaptic plasticity in the perirhinal cortexTannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice.Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.Nerve growth factor, neural stem cells and Alzheimer's disease.Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.Does Endurance Training Compensate for Neurotrophin Deficiency Following Diabetic Neuropathy?ProNGF Drives Localized and Cell Selective Parvalbumin Interneuron and Perineuronal Net Depletion in the Dentate Gyrus of Transgenic MiceVarious drug delivery approaches to the central nervous system.The role of cognitive activity in cognition protection: from Bedside to Bench.
P2860
Q21262018-241F9528-FFD6-422B-8B91-CC1EB19CD243Q22242329-D9FE8B5D-BE43-4D27-B780-CE05AD157E61Q22251261-521180E6-F17D-4A5D-95E9-821AD7611295Q26864804-9981DF90-8784-4B42-9B0D-2353DCEFAC4FQ27349010-11FABB8C-C068-4BDF-A673-73619483FC47Q28247764-1F2E040F-0698-4842-8ECB-98AC2BBD3FBFQ28486102-8A4A82D9-EBCD-4EEB-BF58-F97912C33F16Q28543529-9C6EB0A1-ADB3-4B0F-8010-50E975FE260CQ30362847-CF5BF0AB-5CB0-44F2-98ED-C0917FE9A3A5Q30460369-CE17F27C-18FA-4FB5-A124-547284E415AEQ30460471-8B4D127C-C511-45F8-A970-2C53916776F7Q33264215-A4FD471F-1656-43E3-8419-4CB3549B76B7Q33300810-EB3DA045-8E0A-4EB2-BED5-CCE44CC5EA18Q33393895-80B29BC3-0D4A-43AC-ACD9-624CE9803135Q33480007-E3CB8D51-E5E7-4B31-9E6D-AF718102714BQ33773562-AA21F1D2-A235-4257-85BC-7B272994665AQ33882182-38FDE34E-1219-46FD-8086-23418FDD0B2EQ33941603-7D8145A1-87BB-4EB2-9D26-A3B51AE9BBCFQ33982246-ABA5EEE1-0FB8-4879-96F9-3B7851D2B6EEQ34019665-55FDEC96-DEB7-4893-A73D-445E98850CCFQ34234714-A2FC8DB9-A3BA-433D-B70A-61667F34FB32Q34292513-2A370AD2-9B6B-4D7F-9595-A146E75A5D49Q34430920-58E9FA9F-AF98-4747-B2A3-323FC096EF79Q34452590-EDD3DC44-3E3B-4C0B-B80C-0C1C8A119690Q34505436-86BD1F8A-7651-47E4-B314-001B00B789DCQ34593290-2706898F-43C4-4014-82EA-0A47DE1B0BFBQ34695275-B2336CBF-6BAE-48EA-BA36-0B8D6E302F44Q34825364-42C466CD-5F41-48AC-9797-B454760D63CCQ34998572-5F856C39-5228-4198-A01D-6DAAD67F46DDQ35636272-813C38D4-019E-448B-9629-0E3F6E672165Q35838871-EB5B6109-7152-46B9-8D09-A4C2AEA0762CQ36329164-6D73CC18-ECE0-4E98-A0BA-E8D833941581Q36529555-5531C9EB-57D7-4D08-B97C-3931CE7C20DAQ36883772-A245D601-C6C0-45A3-9134-549EB2D96D67Q37312849-FFB57EBD-430B-4384-924A-75A9B50AE09EQ37416147-545762D5-71B0-4F66-A89A-4C67272E5D69Q37624565-B5784776-C814-44ED-8DFF-F1DDB095DD53Q37633907-36612F54-74FC-4864-B67D-68411AF9DC2FQ37657525-AC7682DC-5F78-40C1-8D42-46C251B86983Q37726908-204D51CF-7B64-4D7F-96A4-9A50BABEC2B7
P2860
Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Intranasal administration of n ...... AD11 anti-NGF transgenic mice
@ast
Intranasal administration of n ...... AD11 anti-NGF transgenic mice
@en
type
label
Intranasal administration of n ...... AD11 anti-NGF transgenic mice
@ast
Intranasal administration of n ...... AD11 anti-NGF transgenic mice
@en
prefLabel
Intranasal administration of n ...... AD11 anti-NGF transgenic mice
@ast
Intranasal administration of n ...... AD11 anti-NGF transgenic mice
@en
P2093
P2860
P356
P1476
Intranasal administration of n ...... AD11 anti-NGF transgenic mice
@en
P2093
Addys Ancheta Garcia
Antonino Cattaneo
Chiara Braschi
Lamberto Maffei
Nicoletta Berardi
Roberta De Rosa
Simona Capsoni
P2860
P304
P356
10.1073/PNAS.0500195102
P407
P577
2005-02-23T00:00:00Z